Neuronal and Network Mechanisms of Electrocortical Stimulation
1 other identifier
interventional
65
1 country
3
Brief Summary
Electrocortical stimulation (ECS) mapping is a procedure used during brain surgeries, for example when treating diseases like epilepsy or when removing brain tumors. ECS mapping helps surgeons locate areas of the cerebral cortex (the outer part of the brain) that are important for everyday tasks like movement and speech. ECS mapping has been used for decades, and is considered the "gold-standard" tool for locating important areas of cortex. Despite this long history, there is still no clear understanding of exactly how ECS works. The goal of this study is to learn details about the effects ECS has on the brain. The main questions the study aims to answer are: 1) how ECS affects the neurons of the cortex at the stimulation site; and 2) how ECS impacts brain regions that are critically important for human speech and language. These so-called "critical sites" can be physically distant from one another on the brain's surface, requiring extensive ECS mapping and long surgeries. Critical sites are thought to be part of a speech/language network of brain areas, and so the study's goal is to learn about how they are connected. In some participants, the brain's surface will also be slightly cooled. This is a painless procedure that does not harm the brain's function, but could provide insight as to which parts of the brain (the surface, or deeper parts) are responsible for the effects of ECS. By improving the understanding of how ECS affects the brain and improving the ability to identify critical sites, this study could potentially lead to shorter surgeries and better outcomes for future individuals who need this care. Participants will be recruited from among individuals who are undergoing brain surgery for epilepsy treatment or tumor removal. Participants will complete simple tasks like reading words or naming pictures, similar to standard testing that is already performed during their hospital stay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2024
CompletedFirst Posted
Study publicly available on registry
April 30, 2024
CompletedStudy Start
First participant enrolled
May 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2030
September 9, 2025
September 1, 2025
5.1 years
April 5, 2024
September 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Critical node decoding performance
Accuracy at decoding critical nodes from network connectivity metrics using machine learning algorithms.
Up to 1 week during ECoG recording
Secondary Outcomes (1)
Language function
Up to 4 hours during ECoG recording
Study Arms (1)
Experimental group
EXPERIMENTALSingle arm of the study
Interventions
Eligibility Criteria
You may qualify if:
- Requiring awake, cortical mapping for brain tumor resection or implantation of intracranial electrodes for extraoperative monitoring for epilepsy
- For extraoperative patients: Planned electrode coverage including at least parts of frontal and temporal or parietal lobes, preferably both anterior (inferior frontal gyrus) and posterior language areas (superior temporal gyrus) in the language dominant hemisphere
- For intraoperative patients: Planned craniotomy including parts of both frontal and temporal anterior and posterior language areas in the language dominant hemisphere.
You may not qualify if:
- Significant language or speech impairment, including but not limited to aphasia, dysarthria, and apraxia of speech, consistently preventing patient from speaking words
- Non English-speaking (because this is a study of language networks, and second language could be encoded differently)
- Impaired cognitive function, as determined by neurological testing, such that the patient cannot follow test instructions or provide written informed consent
- Tumor infiltrating, or within 1 cm of, multiple of the cortical or subcortical areas studied in this proposal (inferior frontal gyrus, precentral gyrus, superior temporal gyrus)
- Ferromagnetic implants that are MRI incompatible or other contraindications to MRI
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwestern Universitylead
- Johns Hopkins Universitycollaborator
- University of Iowacollaborator
- Indiana Universitycollaborator
Study Sites (3)
Northwestern University
Chicago, Illinois, 60611, United States
University of Iowa
Iowa City, Iowa, 52242, United States
Johns Hopkins University
Baltimore, Maryland, 21218, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marc Slutzky
Northwestern University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 5, 2024
First Posted
April 30, 2024
Study Start
May 17, 2024
Primary Completion (Estimated)
June 30, 2029
Study Completion (Estimated)
June 30, 2030
Last Updated
September 9, 2025
Record last verified: 2025-09